Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia
Key PointsOctogenarians and nonagenarians with AML can be treated successfully with VEN-HMA, and a subset of patients (∼25%) have prolonged survival.Reduce